Cohance Lifesciences

quarterly
yearly
ParticularsMar '25Jun '25Sep '25Dec '25Mar '26
Revenue852.47563.48571.17550.71617.28
Expenses675.82492.62487.40505.25580.86
EBITDA241.27126.18136.55101.5196.84
Operating Profit171.3272.9492.5349.7129.10
Profit Before Tax160.8762.7683.7740.6019.91
Net Profit117.1546.4066.3929.028.31
Financial Ratios
Operating Profit Margin26.83%21.50%24.58%17.75%12.97%
Net Profit Margin15.70%9.95%13.33%7.36%2.85%
Earning Per Share (Diluted)3.101.271.930.960.50
Dividends Per Share0.000.000.000.000.00